TOLERANCE TECHNOLOGY

Welcome to the Brand page for “TOLERANCE TECHNOLOGY”, which is offered here for Pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases, systemic lupus erythematosus; rh hemolytic disease of the newborn; antiphospholipid antibody syndrome; grave's disease; myasthenia gravis; hashimoto's thyroiditis; pemphigus; autoimmune hemolytic anemia; autoimmune thrombocytopenia purpura; antibody mediated infertility; sjogre's syndrome; mixed connective tissue disease; glomerulonephritis and goodpasture's syndrome;.

Its status is currently believed to be active. Its class is unavailable. “TOLERANCE TECHNOLOGY” is believed to be currently owned by “LA JOLLA PHARMACEUTICAL COMPANY”.


Owner:
LA JOLLA PHARMACEUTICAL COMPANY
Owner Details
Description:
Pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases, systemic lupus erythematosus; Rh hemolytic disease of the newborn; antiphospholipid antibody syndrome; grave's disease; myasthenia gravis; hashimoto's thyroiditis; pemphigus; autoimmune hemolytic anemia; autoimmune thrombocytopenia purpura; antibody mediated infertility; sjogre's syndrome; mixed connective tissue disease; glomerulonephritis and goodpasture's syndrome;
Categories: PHARMACEUTICAL PREPARATIONS PREVENTION OR